220 related articles for article (PubMed ID: 26656522)
1. NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015.
Carroll PR; Parsons JK; Andriole G; Bahnson RR; Barocas DA; Castle EP; Catalona WJ; Dahl DM; Davis JW; Epstein JI; Etzioni RB; Farrington T; Hemstreet GP; Kawachi MH; Lange PH; Loughlin KR; Lowrance W; Maroni P; Mohler J; Morgan TM; Nadler RB; Poch M; Scales C; Shaneyfelt TM; Smaldone MC; Sonn G; Sprenke P; Vickers AJ; Wake R; Shead DA; Freedman-Cass D
J Natl Compr Canc Netw; 2015 Dec; 13(12):1534-61. PubMed ID: 26656522
[TBL] [Abstract][Full Text] [Related]
2. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.
Carroll PR; Parsons JK; Andriole G; Bahnson RR; Castle EP; Catalona WJ; Dahl DM; Davis JW; Epstein JI; Etzioni RB; Farrington T; Hemstreet GP; Kawachi MH; Kim S; Lange PH; Loughlin KR; Lowrance W; Maroni P; Mohler J; Morgan TM; Moses KA; Nadler RB; Poch M; Scales C; Shaneyfelt TM; Smaldone MC; Sonn G; Sprenkle P; Vickers AJ; Wake R; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2016 May; 14(5):509-19. PubMed ID: 27160230
[TBL] [Abstract][Full Text] [Related]
3. The Case for Tailored Prostate Cancer Screening: An NCCN Perspective.
McDonald ML; Parsons JK
J Natl Compr Canc Netw; 2015 Dec; 13(12):1576-83. PubMed ID: 26656524
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines.
Carroll PR; Parsons JK; Andriole G; Bahnson RR; Barocas DA; Catalona WJ; Dahl DM; Davis JW; Epstein JI; Etzioni RB; Giri VN; Hemstreet GP; Kawachi MH; Lange PH; Loughlin KR; Lowrance W; Maroni P; Mohler J; Morgan TM; Nadler RB; Poch M; Scales C; Shanefelt TM; Vickers AJ; Wake R; Shead DA; Ho M;
J Natl Compr Canc Netw; 2014 Sep; 12(9):1211-9; quiz 1219. PubMed ID: 25190691
[TBL] [Abstract][Full Text] [Related]
5. NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023.
Moses KA; Sprenkle PC; Bahler C; Box G; Carlsson SV; Catalona WJ; Dahl DM; Dall'Era M; Davis JW; Drake BF; Epstein JI; Etzioni RB; Farrington TA; Garraway IP; Jarrard D; Kauffman E; Kaye D; Kibel AS; LaGrange CA; Maroni P; Ponsky L; Reys B; Salami SS; Sanchez A; Seibert TM; Shaneyfelt TM; Smaldone MC; Sonn G; Tyson MD; Vapiwala N; Wake R; Washington S; Yu A; Yuh B; Berardi RA; Freedman-Cass DA
J Natl Compr Canc Netw; 2023 Mar; 21(3):236-246. PubMed ID: 36898362
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer early detection. Clinical practice guidelines in oncology.
National Comprehensive Cancer Network
J Natl Compr Canc Netw; 2004 May; 2(3):190-207. PubMed ID: 19795604
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer early detection clinical practice guidelines in oncology.
Babaian RJ; Partin AW;
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S42-55. PubMed ID: 19795575
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer screening.
Tenke P; Horti J; Balint P; Kovacs B
Recent Results Cancer Res; 2007; 175():65-81. PubMed ID: 17432554
[TBL] [Abstract][Full Text] [Related]
9. Recent Changes in Prostate Cancer Screening Practices and Epidemiology.
Lee DJ; Mallin K; Graves AJ; Chang SS; Penson DF; Resnick MJ; Barocas DA
J Urol; 2017 Dec; 198(6):1230-1240. PubMed ID: 28552708
[TBL] [Abstract][Full Text] [Related]
10. Detection rate of prostate cancer following biopsy among the northern Han Chinese population: a single-center retrospective study of 1022 cases.
Jia Y; Zhu LY; Xian YX; Sun XQ; Gao JG; Zhang XH; Hou SC; Zhang CC; Liu ZX
World J Surg Oncol; 2017 Aug; 15(1):165. PubMed ID: 28851376
[TBL] [Abstract][Full Text] [Related]
11. [Current aspects of prostate cancer screening].
Jalón Monzón A; Escaf Barmadah S; Viña Alonso LM; Jalón Monzón M
Semergen; 2017; 43(5):387-393. PubMed ID: 27562331
[TBL] [Abstract][Full Text] [Related]
12. Evolution and immediate future of US screening guidelines.
Greene KL; Punnen S; Carroll PR
Urol Clin North Am; 2014 May; 41(2):229-35. PubMed ID: 24725485
[TBL] [Abstract][Full Text] [Related]
13. Early detection of prostate cancer.
Loeb S; Cooperberg MR
Urol Clin North Am; 2014 May; 41(2):xiii. PubMed ID: 24725496
[No Abstract] [Full Text] [Related]
14. [The level of evidence for the use of biomarkers in the early detection of prostate cancer].
Lamy PJ; Gauchez AS; Salomon L; Haugh M; Ceraline J; Fulla Y; Georges A; Larré S; Loric S; Luporsi E; Martin PM; Mazerolles C; Molinié V; Mongiat-Artus P; Piffret J; Thuillier F; Perrin P; Rebillard X;
Ann Biol Clin (Paris); 2016; 74(2):227-32. PubMed ID: 27029727
[TBL] [Abstract][Full Text] [Related]
15. Screening for prostate cancer.
Stewart RW; Lizama S; Peairs K; Sateia HF; Choi Y
Semin Oncol; 2017 Feb; 44(1):47-56. PubMed ID: 28395763
[TBL] [Abstract][Full Text] [Related]
16. Screening for prostate cancer: the current evidence and guidelines controversy.
Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R
Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
[TBL] [Abstract][Full Text] [Related]
17. [Early detection or screening in the prevention of prostate cancer?].
Brenes Bermúdez FJ; Alcántara Montero A
Semergen; 2017 Mar; 43(2):100-108. PubMed ID: 26960257
[TBL] [Abstract][Full Text] [Related]
18. Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model.
Mühlberger N; Boskovic K; Krahn MD; Bremner KE; Oberaigner W; Klocker H; Horninger W; Sroczynski G; Siebert U
BMC Public Health; 2017 Jun; 17(1):596. PubMed ID: 28651567
[TBL] [Abstract][Full Text] [Related]
19. The need for active surveillance for low risk prostate cancer.
Drost FH; Roobol MJ
Expert Rev Anticancer Ther; 2017 Jun; 17(6):487-489. PubMed ID: 28406334
[No Abstract] [Full Text] [Related]
20. Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences?
Carroll PR; Vickers AJ
J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):768-71. PubMed ID: 24853213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
